Gabriel E. Zentner
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
166
Citations
5,845
Est. group size
—
Recurring co-author estimate
Active years
52
Publishing since 1974
Gabriel E. Zentner studies how DNA is packaged and regulated inside cells, focusing on chromatin (the protein-DNA structure that organizes genomes) and the proteins that control which genes are turned on or off. Recent work examines gene-regulatory factors such as CTCF and how their disruption relates to cancer, including ovarian cancer cell behavior. The research combines molecular biology with genome-wide mapping techniques to understand gene expression and its dysregulation in disease.
Publication activity has been broadly steady across the decade with a notable spike in 2023, largely driven by many supplementary data items tied to a single study, followed by lower counts in 2024-2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- CDK12/13 inhibition disrupts nucleolar morphology and promotes aberrant expression of IGS transcripts
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Data from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Data from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplemental Figure Legends 1-9 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 6 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 2 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplemental Figure Legends 1-9 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Data from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 1 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 5 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 2 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Data from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 5 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 4 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- Supplementary Table 1 from <i>BORIS</i> Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through <i>GALNT14</i>
2023
- bioRxiv (Cold Spring Harbor Laboratory)×16
- PLoS Genetics×3
- Molecular Cancer Research×2
- Scientific Reports×2
- Methods in molecular biology×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile